| Stage | LLY | % of rev | AVGO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $24.4B | 100.00% | $29.6B | 100.00% | AVGO ×1.21 |
| Gross profit | $20.5B | 83.88% | $20.5B | 69.13% | LLY +14.8pp |
| Operating income | $8.6B | 35.28% | $16.0B | 53.92% | AVGO +18.6pp |
| Pre-tax income | $8.4B | 34.46% | $15.3B | 51.62% | AVGO +17.2pp |
| Net income | $6.5B | 26.44% | $13.1B | 44.23% | AVGO +17.8pp |
| Stage | LLY | AVGO | Gap · A − B |
|---|---|---|---|
| Revenue | $24.4B100.00% | $29.6B100.00% | AVGO ×1.21 |
| Gross profit | 83.88%$20.5B | 69.13%$20.5B | LLY +14.8pp |
| Operating income | 35.28%$8.6B | 53.92%$16.0B | AVGO +18.6pp |
| Pre-tax income | 34.46%$8.4B | 51.62%$15.3B | AVGO +17.2pp |
| Net income |
| 26.44%$6.5B |
| 44.23%$13.1B |
| AVGO +17.8pp |
No shared counterparties.